Viewing Study NCT00468351


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-10 @ 6:45 PM
Study NCT ID: NCT00468351
Status: UNKNOWN
Last Update Posted: 2007-05-02
First Post: 2007-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)
Sponsor: University of Sao Paulo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module